MARIA CLARA
ALVAREZ VILLAMARIN
University professor
Publications (83) MARIA CLARA ALVAREZ VILLAMARIN publications
2024
-
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe
Endocrine, Vol. 83, Núm. 3, pp. 585-593
2022
-
Data mining analyses for precision medicine in acromegaly: a proof of concept
Scientific Reports, Vol. 12, Núm. 1
-
LEAP-2 Counteracts Ghrelin-Induced Food Intake in a NutrientGrowth Hormone and Age Independent Manner
Cells, Vol. 11, Núm. 3
-
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
Healthcare (Switzerland), Vol. 10, Núm. 9
-
The Inflammatory Pattern of Chronic Limb-Threatening Ischemia in Muscles: The TNF-α Hypothesis
Biomedicines, Vol. 10, Núm. 2
2021
-
Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling
Cancers, Vol. 13, Núm. 16
-
Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis
Cell Metabolism, Vol. 33, Núm. 9, pp. 1820-1835.e9
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
-
RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas
Oncogene, Vol. 40, Núm. 45, pp. 6354-6368
-
Synthesis and in vivo evaluation of insulin-loaded whey beads as an oral peptide delivery system
Pharmaceutics, Vol. 13, Núm. 5
-
The Authors Reply PMC and PMT: Real Medicine and Not Just Biology
American Journal of Surgical Pathology
2020
-
GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells
Frontiers in Endocrinology, Vol. 11
-
Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo
Journal of Controlled Release, Vol. 317, pp. 118-129
-
Molecular profiling for acromegaly treatment: a validation study
Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389
-
Sequential colocalization of ERa, PR, and AR hormone receptors using confocal microscopy enables new insights into normal breast and prostate tissue and cancers
Cancers, Vol. 12, Núm. 12, pp. 1-22
-
Thyroid papillary microtumor: Validation of the (updated) porto proposal assessing sex hormone receptor expression and mutational BRAF gene status
American Journal of Surgical Pathology, Vol. 44, Núm. 9, pp. 1161-1172
-
Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial
Cells, Vol. 9, Núm. 4
2019
-
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, Núm. 11, pp. 1843
-
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
EBioMedicine, Vol. 43, pp. 537-552